A bold effort to cure HIV—using Crispr
Enlarge / A 3D illustration of the HIV virus. (credit: Westend61 / Getty)
In July, an HIV-positive man became the first volunteer in a clinical trial aimed at using Crispr gene editing to snip the AIDS-causing virus out of his cells. For an hour, he was hooked up to an IV bag that pumped the experimental treatment directly into his bloodstream. The one-time infusion is designed to carry the gene-editing tools to the man's infected cells to clear the virus.
Later this month, the volunteer will stop taking the antiretroviral drugs he's been on to keep the virus at undetectable levels. Then, investigators will wait 12 weeks to see if the virus rebounds. If not, they'll consider the experiment a success. What we're trying to do is return the cell to a near-normal state," says Daniel Dornbusch, CEO of Excision BioTherapeutics, the San Francisco-based biotech company that's running the trial.